Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 802 results for "eisai"

Eisai Inc. Announces Final Results From Phase 3 Open-Label Study Of Rufinamide At American Epilepsy Society Annual Meeting

Eisai Announces New Analyses and Data on Perampanel at America...

WOODCLIFF LAKE, N.J., Dec. 5, 2016 /PRNewswire/ -- Eisai Inc. announced today new analyses and data on perampanel presented at the 2016 Annual Meeting of the American Epilepsy Society (AES). Perampanel, marketed as FYCOMPA® CIII, is indicated as an ..., 2 days ago

91 images for eisai

BioSpace, 2 days ago
Yahoo! Singapore, 2 days ago
PharmaVOICE, 6 days ago
DirectorsTalk, 3 days ago
Pharmafile, 1 week ago
PR Newswire, 1 week ago
WorldNetDaily, 1 week ago
Shares Magazine, 1 week ago
Scrip Intelligence, 2 weeks ago
Ticker Report, 1 month ago

Halaven® (eribulin) Receives Registration in South Africa for Treatment of Women With Advanced Breast Cancer

/PRNewswire/ -- FOR EMEA MEDIA ONLY: NOT FOR SWISS/AUSTRIAN MEDIA Collaboration between Eisai and Clinigen provides women in South Africa with access to eribulin for advanced breast cancer Halaven® (eribulin) is now registered by the Medicines ...
 Yahoo! Finance1 week ago Eisai & Clinigen to bring breast cancer drug to South Africa  Pharmafile1 week ago Clinigen collaborates with Eisai in South Africa  Shares Magazine1 week ago Eisai Company Release: Halaven (Eribulin) Receives Registration In South Africa For Treatment Of Women With Advanced Breast Cancer  BioSpace6 days ago

Eisai's BACE inhibitor for early Alzheimer's Fast Track'd in U.S.

The FDA designates Eisai's ( OTC:ESALF )( OTCPK:ESALY ) Phase 3-stage E2609 for Fast Track review for the treatment of early Alzheimer's disease. Fast Track status allows for more frequent interactions with the FDA review team and a rolling ...
 Seeking Alpha3 weeks ago

Eisai Initiates Phase II Study of Dual Orexin Receptor Antagonist Lemborexant in People with Irregular Sleep-Wake Rhythm Disorder (ISWRD) and Dementia

/PRNewswire/ -- FOR UK MEDIA ONLY: NOT FOR AUSTRIAN/SWISS JOURNALISTS Eisai today announces the initiation of a multicentre, randomised phase II clinical study of lemborexant (development code: E2006) in people with Irregular Sleep-Wake Rhythm ...
 Yahoo! Finance1 month ago

Eisai and Arena Pharmaceuticals Announce Presentation of BELVIQ® (lorcaserin HCl) Data at 2016 Annual Obesity..

Arena (NASDAQ:ARNA) Intraday Stock Chart Today : Thursday 3 November 2016 WOODCLIFF LAKE, N.J. and SAN DIEGO , Nov. 3, 2016 /PRNewswire/ --Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the presentation of one oral ...
 ADVFN India1 month ago

Eisai latest cancer drugmaker to win UK approval after price cut

LONDON (Reuters) - Cancer drugmakers are cutting prices to ensure their medicines are used routinely on Britain's National Health Service, following the overhaul of a cancer drug funding scheme, with Japan's Eisai the latest to win approval. The ...
 Yahoo! India1 month ago

Considerable Additional Benefit of Eisai's Halaven® (eribulin) in Advanced Liposarcoma Confirmed by the German Federal Joint Committee (G-BA)

/PRNewswire/ -- FOR EMEA MEDIA ONLY: NOT FOR SWISS/AUSTRIAN JOURNALISTS Eribulin has shown unprecedented survival benefit in advanced liposarcoma in pivotal phase III trial [1] The German Federal Joint Committee (G-BA) has confirmed ...
 Yahoo! Singapore3 days ago Wealth of Data for Fycompa® (perampanel) and Inovelon® (rufinamide) to be Presented at the American Epilepsy Society (AES) Annual Meeting  Ariva.de1 week ago Results Presented for Pivotal Phase III Clinical Trial of Adjunctive Rufinamide in Children With Inadequately Controlled Lennox-Gastaut Syndrome  Wallstreet Online2 days ago New Data for Once-​daily Adjunctive Zebinix® (eslicarbazepine acetate) Show Good Seizure Control and Tolerability in People With Partial Onset (Focal) Seizures  Ariva.de3 days ago

Eisai wins NICE backing for older Halaven but still isn't happy about Lenvima

After weighing new data and a discount, England's drug-cost watchdogs backed Eisai's Halavento treat advanced breast cancer, making it the first drugto win a green lightin breast cancer in nearly a decade. Since NICE's initial rejection four ...
 FiercePharma1 month ago Eisai's breast cancer drug approved by NICE in draft guidance  Pharma Letter1 month ago Eisai Welcomes Positive NICE recommendation for Halaven® (eribulin) for Patients with Locally Advanced or Metastatic Breast Cancer  PharmiWeb1 month ago NICE finally recommends Eisai breast cancer drug after rethink  pharmaphorum1 month ago

Lennox-Gastaut Syndrome: Awareness Makes a Family's Struggle More Manageable

(BPT) - This post is brought to you by Eisai Inc. When Christina SanInocencio was just seven years old, she witnessed her three-year-old brother Michael have what would be his first of many seizures. It wasn't until two years later that he ...
 High Plains Journal2 hours ago

Eisai and Oklahoma Medical Research Foundation Launch Lupus Research Collaboration

The Oklahoma Medical Research Foundation (OMRF), an independent non-profit biomedical research institute, will enter a new research collaboration with Eisai, an oncology and neurology-oriented pharmaceutical, to study the genetics oflupus. ...
 DirectorsTalk3 days ago Global Arthritis Partnering Deals and Agreements Analysis 2010-2016 - Research and Markets  4 Traders2 hours ago Corporate Reputation of Pharma 2015 - The Perspective of 280 Patient Groups with an Interest in Cancer - Research and Markets  4 Traders2 days ago Medical Science Liaisons in Oncology (2016): How Oncologists Engage with 20 Biopharmaceutical Manufacturer's MSLs - Research and Markets  Business Wire1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less